Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature (Q40270911)
Jump to navigation
Jump to search
scientific article published on January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature |
scientific article published on January 2006 |
Statements
1 reference
Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature (English)
1 reference
Lila Adnane
1 reference
Pamela A Trail
1 reference
Ian Taylor
1 reference
Scott M Wilhelm
1 reference
1 January 2006
1 reference
1 reference
407
1 reference
597-612
1 reference
Identifiers
1 reference
1 reference